Canadian Cancer Trials Group Bulletins

General


ASCO 2011

Twenty-seven abstracts related to Canadian Cancer Trials Group trials or trials which included Canadian Cancer Trials Group participation are being presented at the American Society of Clinical Oncology Annual Meeting in Chicago, IL, June 3-7, 2011, including three that have been chosen as "Best of ASCO"!!! These include Canadian Cancer Trials Group MA.20, Canadian Cancer Trials Group MAP.3, and Canadian Cancer Trials Group PR.7.

In addition, MA.20 and MAP.3 were chosen to be included in ASCO's Official Press Program and will be highlighted during a press conference on Saturday, June 4.

MA.20 - Timothy J. Whelan
Highlighted in ASCO Official Press Program and selected for Best of ASCO
Canadian Cancer Trials Group MA.20: An Intergroup Trial of Regional Nodal Irradiation in Early Breast Cancer
(Abstract LBA1003)
Oral Abstract Session - Breast Cancer - Triple-negative/Cytotoxics/Local Therapy
Monday: 9:30 AM - 12:30 PM, Location: Hall B1
Presentation Time: 9:45 AM - 10:00 AM

MAP.3 - Paul E. Goss
Highlighted in ASCO Official Press Program and selected for Best of ASCO
Exemestane for primary prevention of breast cancer in postmenopausal women: Canadian Cancer Trials Group MAP.3 - A randomized placebo-controlled clinical trial. (Abstract LBA504)
Oral Abstract Session - Breast Cancer - HER2/ER
Sunday: 9:00 AM - 12:00 PM, Location: Hall B1
Presentation Time: 9:00 AM - 9:15 AM

PR.7 - Juanita M. Crook - Selected for Best of ASCO
A phase III randomized trial of intermittent versus continuous androgen suppression for PSA progression after radical therapy (Canadian Cancer Trials Group PR.7/SWOG JPR.7/CTSU JPR.7/ UK Intercontinental Trial CRUKE/ 01/013). (Abstract 4514)
Oral Abstract Session - Genitourinary Cancer (Prostate)
Monday: 1:00 PM - 4:00 PM, Location: Hall D1
Presentation Time: 2:30 PM - 2:45 PM

For a complete listing of abstracts being presented, please use this link ... http://www.ctg.queensu.ca/public/publications/ASCO-2011.pdf.